Mid-Day Breakouts Report - Thursday, June 23rd, 2022

<<<Previous Mid Day Report	Next Mid Day Report >>>
<<<Previous After Market Report	Next After Market Report >>>

You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Monday, October 21, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

MIDDAY BREAKOUTS REPORT - THURSDAY, JUNE 23RD, 2022
Previous Mid Day Report Next Mid Day Report >>>

DOW 30472.32 -10.81 (-0.04%) | NASDAQ 11158.85 105.77 (0.96%) | S&P 500 3772.18 12.29 (0.33%)

Time of Screening : 6/23/2022 12:01:14 PM Report Released : 6/23/2022 12:25:09 PM
Price is: Above 52W High and Less Than 52W High but within 15% of the 52 Week High
Volume Is: At least 50% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page

NONE OF OUR FEATURED STOCKS MET TODAY'S SCREENING CRITERIA FOR VOLUME AND PRICE ACTION.

Symbol - Exchange - Industry Group Company Name	Last	Chg	Day High	52 WK Hi	% From Hi	Volume % DAV	DAV
DGICA - NASDAQ - Insurance-Prop/Cas/Titl Donegal Group Inc Cl A	$16.15	+0.01 0.06%	$16.28	$16.50	-2.12%	46,634 56.87%	82,000
Most Recent Note for DGICA - 6/23/2022 12:02:44 PM Prior mid-day reports repeatedly cautioned members - "Perched within close striking distance of its 52-week high. Reported earnings +48% on +5% sales revenues for the Mar '22 quarter versus the year ago period. Prior quarterly sales revenues and earnings growth has not been strong and steady. Annual earnings (A criteria) history also has been up and down."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
FNKO - NASDAQ - Leisure-Toys/Games/Hobby Funko Inc Cl A	$23.74	+2.74 13.05%	$24.19	$23.05	2.99%	1,305,309 200.82%	650,000
Most Recent Note for FNKO - 6/23/2022 12:04:29 PM Gapped up today for a big volume-driven gain following an analyst upgrade, rallying toward its May 2021 high. Quarterly comparisons through Mar '22 showed strong earnings increases (C criteria) with great sales revenues growth. Annual earnings (A criteria) history remains a concern after a big downturn in FY '20.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
GEF - NYSE - Containers/Packaging Greif Inc Cl A	$62.40	+3.66 6.23%	$62.86	$72.00	-13.33%	152,547 74.05%	206,000
Most Recent Note for GEF - 6/23/2022 12:07:10 PM Rebounding above its 50 and 200 DMA lines with today's gain. Stalled after volume-driven gains since the 6/09/22 mid-day report last noted - "Recent quarterly earnings increases through Mar '22 versus the year ago period were well above the +25% minimum guideline (C criteria). Annual earnings history (A criteria) had a downturn in FY '20, not a match with the fact-based investment system's strict fundamental guidelines."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
HURN - NASDAQ - DIVERSIFIED SERVICES - Business/Management Services Huron Consulting Grp Inc	$62.65	+2.38 3.96%	$63.59	$62.02	1.02%	269,861 191.39%	141,000
Most Recent Note for HURN - 6/23/2022 12:08:56 PM Hitting new multi-year highs with today's 3rd consecutive volume-driven gain. Consolidated above its 50 DMA line since noted in the 5/10/22 mid-day report - "Reported earnings +40% on +29% sales revenues for the quarter ended March 31, 2022 versus the year ago period, its 3rd consecutive quarterly comparison above the +25% minimum earnings guideline (C criteria). Up and down annual earnings (A criteria) history is not a good match with the guidelines of the fact-based system. It survived but failed to impress since dropped from the Featured Stocks list on 8/15/2007."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
NBN - NASDAQ - BANKING - Regional - Northeast Banks Northeast Bancorp	$35.52	-1.33 -3.61%	$37.61	$41.05	-13.47%	28,743 71.86%	40,000
Most Recent Note for NBN - 6/23/2022 12:10:27 PM Testing support at its 200 DMA line. Prior mid-day reports noted - "Reported Mar '22 quarterly earnings +4% on -55% sales revenues versus the year ago period, breaking a streak of strong quarterly comparisons."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
NL - NYSE - Hsehold/Office Furniture N L Industries	$9.33	-0.16 -1.70%	$9.91	$9.92	-5.96%	19,245 56.60%	34,000
Most Recent Note for NL - 6/23/2022 12:11:34 PM Reversed into the red after early gains today challenging the prior high. Found support well above its 50 DMA line after rallying from a sound base pattern in recent weeks. Prior mid-day reports cautioned members - "Earnings and sales revenues history is below the fact-based investment system's guidelines."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
NVO - NYSE - DRUGS - Drug Manufacturers - Other Novo Nordisk A/S Adr	$108.07	+0.73 0.68%	$108.37	$122.16	-11.54%	915,249 60.29%	1,518,000
Most Recent Note for NVO - 6/23/2022 12:12:21 PM This Denmark-based Medical - Ethical Drug firm is consolidating below its 50 and finding support near its 200 DMA line. Prior mid-day reports repeatedly cautioned members - "Fundamental concerns remain after it reported Mar '22 quarterly earnings +8% on +17% sales revenues versus the year ago period."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
PKBK - NASDAQ - BANKING - Regional - Northeast Banks Parke Bancorp Inc	$22.11	+0.10 0.45%	$22.19	$25.85	-14.47%	22,173 51.57%	43,000
Most Recent Note for PKBK - 6/23/2022 12:12:42 PM Sputtering below its 50 DMA and 200 DMA lines following recently noted volume-driven losses. Fundamental concerns remain.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
RGP - NASDAQ - Comml Svcs-Consulting Resources Connection Inc	$18.41	-0.29 -1.55%	$19.42	$20.16	-8.68%	117,467 62.15%	189,000
Most Recent Note for RGP - 6/23/2022 12:14:48 PM Reversed into the red after early gains today challenging its 52-week high. Feb '22 quarterly earnings rose +364% on +31% sales revenues versus the year ago period. Last noted with caution in the 4/08/22 mid-day report - "Reported strong Nov '21 quarterly results +124% on +31% sales revenues versus the year ago period, its 2nd strong quarter. Fundamental concerns remain."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
SAFM - NASDAQ - FOOD & BEVERAGE - Meat Products Sanderson Farms Inc	$211.90	+3.38 1.62%	$212.67	$214.83	-1.36%	159,216 56.26%	283,000
Most Recent Note for SAFM - 6/23/2022 12:16:23 PM Perched at its all-time high after heavy volume behind big gains in recent weeks. Prior mid-day reports noted - "Reported very strong sales revenues and earnings increases in quarterly comparisons through Apr '22 versus the year ago periods. Sub par annual earnings (A criteria) history is not a match with the fact-based investment system's guidelines. Consolidating since M&A news 8/09/21 with Cargill."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
UNH - NYSE - HEALTH SERVICES - Health Care Plans Unitedhealth Group Inc	$499.19	+9.51 1.94%	$503.58	$553.29	-9.78%	1,607,017 50.74%	3,167,000
Most Recent Note for UNH - 6/23/2022 12:18:42 PM Rebounded above its 200 DMA line ($472) this week and traded above its 50 DMA line ($498) early today with its 3rd consecutive volume-driven gain. Prior mid-day reports cautioned members - "Reported earnings +3% on +14% sales revenues for the quarter ended March 31, 2022 versus the year ago period. Prior comparisons were erratic, not strong and steady above the +25% minimum guideline (C criteria). Annual earnings growth has been strong and steady."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
VIVO - NASDAQ - DRUGS - Diagnostic Substances Meridian Bioscience Inc	$29.95	+0.20 0.67%	$30.21	$30.21	-0.86%	182,822 54.41%	336,000
Most Recent Note for VIVO - 6/23/2022 12:19:38 PM Today's 4th consecutive volume-driven gain has it challenging its 52-week high. Prior mid-day reports cautioned members - "Quarterly earnings increases through Mar '22 versus the year ago periods have been below the +25% minimum guideline (C criteria). Up and down annual earnings (A criteria) history is not a match with the fact-based investment system's fundamental guidelines. On 4/18/08 it was dropped from the Featured Stocks list."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
VRTX - NASDAQ - Medical-Biomed/Biotech Vertex Pharmaceuticals	$280.97	+8.66 3.18%	$281.96	$292.75	-4.02%	1,041,867 61.39%	1,697,000
Most Recent Note for VRTX - 6/23/2022 12:22:40 PM Rebounded above its 50 DMA line ($265) recently and challenging prior highs with today's 4th consecutive gain. Reported earnings +18% on +22% sales revenues for the Mar '22 quarter versus the year-ago period, below the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) history has been strong.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
WEYS - NASDAQ - CONSUMER NON-DURABLES - Textile - Apparel Footwear Weyco Group Inc	$31.60	+1.30 4.29%	$32.45	$31.17	1.38%	83,181 268.33%	31,000
Most Recent Note for WEYS - 6/23/2022 12:25:00 PM Hitting a new 52-week high with today's 4th consecutive volume-driven gain. Prior mid-day reports cautioned members - "Recent quarterly comparisons through Mar '22 versus the year ago periods showed great increases in sales revenues and earnings. Annual earnings included a loss in FY '20, not a match with the fundamental guidelines of the fact-based investment system."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M

THESE ARE NOT BUY RECOMMENDATIONS! Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time. Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

We appreciate any feedback members may wish to send via the inquiry form here.